ACM
SOPH icon

AIGH Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

AIGH Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8M Buy
+3,954,194
New +$20.1M 1.44% 15

Other funds holding SOPH

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

AIGH Capital Management's SOPH Position: Q2 2026 in Review

AIGH Capital Management opened a new position in SOPHiA GENETICS (SOPH) in Q2 2026: 3,954,194 shares worth $22.8M. The stake represents 1.44% of the portfolio and ranks #15 among its holdings.

26 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • AIGH Capital Management held 3,954,194 shares of SOPHiA GENETICS worth $22.8M as of Q2 2026.
  • SOPHiA GENETICS was a new AIGH Capital Management position in Q2 2026.
  • SOPHiA GENETICS made up 1.44% of AIGH Capital Management's portfolio in Q2 2026, its #15 holding.
  • 26 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.